13F-HR filed by Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 27 holding rows worth $111,726,254.
- Accession
- 0001012975-26-000144
- Filer
- CIK 1782539
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A combination report, 27 entries on the cover page, a total value of $111,726,254 stated on the cover page (in dollars after the unit check, H1), rows summing to $111,726,254 with VALUE read as dollars as filed, 13F file number 028-21371. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerPivotal bioVenture Partners Investment Advisor LLC028-20630
- reports for this filerPivotal bioVenture Partners Fund I U.G.P. Ltd028-20631
- included managerPivotal bioVenture Partners Investment Advisor LLC028-20630
- included managerPivotal bioVenture Partners Fund I U.G.P. Ltd028-20631
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 1,441,032 | $24,670,468 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 971,253 | $17,060,059 | dollars as filed | |
| OCULIS HOLDING AG | H5870P102 | CMN | 514,702 | $10,278,599 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 11,872 | $6,913,540 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 300,000 | $6,678,000 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 59,022 | $5,829,603 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 49,120 | $5,257,805 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 15,722 | $4,776,501 | dollars as filed | |
| PROCORE TECHNOLOGIES INC COM | 74275K108 | Stock | 53,299 | $3,876,969 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 460,000 | $3,762,800 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 13,600 | $2,900,064 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 102,984 | $2,750,703 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 595,287 | $2,434,724 | dollars as filed | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 1,883,179 | $2,410,469 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 30,875 | $2,402,384 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 2,800 | $2,354,660 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 19,253 | $1,533,501 | dollars as filed | |
| iShares Ethereum Trust | 46438R105 | COM | 50,549 | $1,133,814 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 27,049 | $1,012,174 | dollars as filed | |
| IShares Bitcoin Trust Registered | 46438F101 | SHS | 15,968 | $792,811 | dollars as filed | |
| RANI THERAPEUTICS HLDGS INC | 753018100 | CMN | 493,584 | $666,338 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 63,719 | $619,349 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 49,082 | $504,563 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 68,943 | $488,116 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702203 | COM NEW | 58,347 | $319,041 | dollars as filed | |
| ROCKETLABCORPCLASSCLASSA | 773121108 | STOK | 3,824 | $266,762 | dollars as filed | |
| Bolt Projects Holdings Inc. | 09769B206 | COM | 40,597 | $32,437 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-26-000144 | this filing | 2026-02-13 | acceptance time not in the bulk data set |